SOPHiA AI Becomes the Technology of Choice for Clinical Diagnostic in Latin America

Sophia Genetics, global leader in Data-Driven Medicine, announced today that ten new genomic institutions from Latin America have started using SOPHiA – the company’s AI – to democratize access to clinical genomics on the continent, and improve patient diagnosis and care.

Please to read the entire article.